HLA-G-mediated NK cell senescence promotes vascular remodeling: Implications for reproduction

Cellular and Molecular Immunology

Volumn 11, Issue 5, 2014, Pages 460-466

  Rajagopalan, Sumati ^a  

^a NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

Author keywords

cellular senescence; HLA G; KIR2DL4; natural killer cells; pregnancy

Indexed keywords

DRUG COMBINATION; ESTRADIOL; HLA G ANTIGEN; KILLER CELL IMMUNOGLOBULIN LIKE RECEPTOR 2DL4; KIR2DL4 PROTEIN, HUMAN; NANDROLONE; PROGESTERONE DERIVATIVE; TROPHOBOLEN;

ANALOGS AND DERIVATIVES; ANIMAL; CELL AGING; DRUG COMBINATION; FEMALE; HUMAN; IMMUNOLOGY; NATURAL KILLER CELL; PREGNANCY; REPRODUCTION; UTERUS; VASCULAR REMODELING;

ANIMALS; CELL AGING; DRUG COMBINATIONS; ESTRADIOL; FEMALE; HLA-G ANTIGENS; HUMANS; HYDROXYPROGESTERONES; KILLER CELLS, NATURAL; NANDROLONE; PREGNANCY; RECEPTORS, KIR2DL4; REPRODUCTION; UTERUS; VASCULAR REMODELING;

EID: 84906848480     PISSN: 16727681     EISSN: None     Source Type: Journal    
DOI: 10.1038/cmi.2014.53     Document Type: Review

References (67)

1. Lanier LL. NK cell recognition. Annu Rev Immunol 2005; 23: 225-274.
2. Moffett-King A. Natural killer cells and pregnancy. Nat Rev Immunol 2002; 2: 656-663.
3. Vivier E, Raulet DH, Moretta A, Caligiuri MA, Zitvogel L, Lanier LL et al. Innate or adaptive immunity? The example of natural killer cells. Science 2011; 331: 44-49.
4. Sun JC, Lanier LL. Natural killer cells remember: an evolutionary bridge between innate and adaptive immunity? Eur J Immunol 2009; 39: 2059-2064.
5. Zhang J, Chen Z, Smith GN, Croy BA. Natural killer cell-triggered vascular transformation: maternal care before birth? Cell Mol Immunol 2010; 8: 1-11.
6. Erlebacher A. Immunology of the maternal-fetal interface. Annu Rev Immunol 2013; 31: 387-411.
7. Croy BA, Esadeg S, Chantakru S, van den Heuvel M, Paffaro VA, He H et al. Update on pathways regulating the activation of uterine Natural Killer cells, their interactions with decidual spiral arteries and homing of their precursors to the uterus. J Reprod Immunol 2003; 59: 175-191.
8. Bulmer JN, Lash GE. Human uterine natural killer cells: a reappraisal. Mol Immunol 2005; 42: 511-521.
9. Hanna J, Goldman-Wohl D, Hamani Y, Avraham I, Greenfield C, Natanson-Yaron S et al. Decidual NK cells regulate key developmental processes at the human fetal-maternal interface. Nat Med 2006; 12: 1065-1074.
10. Kopcow HD, Allan DS, Chen X, Rybalov B, Andzelm MM, Ge B et al. Human decidual NK cells form immature activating synapses and are not cytotoxic. Proc Natl Acad Sci USA 2005; 102: 15563-15568.
11. Le Bouteiller P. Human decidual NK cells: unique and tightly regulated effector functions in healthy and pathogen-infected pregnancies. Front Immunol 2013; 4: 404.
12. Siewiera J, El Costa H, Tabiasco J, Berrebi A, Cartron G, Le Bouteiller P et al. Human cytomegalovirus infection elicits new decidual natural killer cell effector functions. PLoS Pathog 2013; 9: e1003257.
13. Trowsdale J, Moffett A. NK receptor interactions with MHC class I molecules in pregnancy. Semin Immunol 2008; 20: 317-320.
14. Carosella ED, Favier B, Rouas-Freiss N, Moreau P, Lemaoult J. Beyond the increasing complexity of the immunomodulatory HLA-G molecule. Blood 2008; 111: 4862-4870.
15. Rajagopalan S, Fu J, Long EO. Cutting edge: induction of IFN-gamma production but not cytotoxicity by the killer cell Ig-like receptor KIR2DL4 (CD158d) in resting NK cells. J Immunol 2001; 167: 1877-1881.
16. van der Meer A, Lukassen HG, van Lierop MJ, Wijnands F, Mosselman S, Braat DD et al. Membrane-bound HLA-G activates proliferation and interferon-gamma production by uterine natural killer cells. Mol Hum Reprod 2004; 10: 189-195.
17. van der Meer A, Lukassen HG, van Cranenbroek B, Weiss EH, Braat DD, van Lierop MJ et al. Soluble HLA-G promotes Th1-type cytokine production by cytokine-activated uterine and peripheral natural killer cells. Mol Hum Reprod 2007; 13: 123-133.
18. Li C, Houser BL, Nicotra ML, Strominger JL. HLA-G homodimer-induced cytokine secretion through HLA-G receptors on human decidual macrophages and natural killer cells. Proc Natl Acad Sci USA 2009; 106: 5767-5772.
19. Rouas-Freiss N, Goncalves RM, Menier C, Dausset J, Carosella ED. Direct evidence to support the role of HLA-G in protecting the fetus from maternal uterine natural killer cytolysis. Proc Natl Acad Sci USA 1997; 94: 11520-11525.
20. Rouas-Freiss N, Marchal RE, Kirszenbaum M, Dausset J, Carosella ED. The alpha1 domain of HLA-G1 and HLA-G2 inhibits cytotoxicity induced by natural killer cells: is HLA-G the public ligand for natural killer cell inhibitory receptors? Proc Natl Acad Sci USA 1997; 94: 5249-5254.
21. Riteau B, Menier C, Khalil-Daher I, Martinozzi S, Pla M, Dausset J et al. HLA-G1 co-expression boosts the HLA class I-mediated NK lysis inhibition. Int Immunol 2001; 13: 193-201.
22. Rizzo R, Vercammen M, van de Velde H, Horn PA, Rebmann V. The importance of HLA-G expression in embryos, trophoblast cells, and embryonic stem cells. Cell Mol Life Sci 2010; 68: 341-352.
23. Parham P. MHC class I molecules and KIRs in human history, health and survival. Nat Rev Immunol 2005; 5: 201-214.
24. Long EO, Sik Kim H, Liu D, Peterson ME, Rajagopalan S. Controlling natural killer cell responses: integration of signals for activation and inhibition. Annu Rev Immunol. 2013; 31: 227-258.
25. Parham P, Guethlein LA. Pregnancy immunogenetics: NK cell education in the womb? J Clin Invest 2010; 120: 3801-3804.
26. Hiby SE, Walker JJ, O'Shaughnessy KM, Redman CW, Carrington M, Trowsdale J et al. Combinations of maternal KIR and fetal HLA-C genes influence the risk of preeclampsia and reproductive success. J Exp Med 2004; 200: 957-965.
27. Hiby SE, Apps R, Sharkey AM, Farrell LE, Gardner L, Mulder A et al. Maternal activating KIRs protect against human reproductive failure mediated by fetal HLA-C2. J Clin Invest 2010; 120: 4102-4110.
28. Kieckbusch J, Gaynor LM, Moffett A, Colucci F. MHC-dependent inhibition of uterine NK cells impedes fetal growth and decidual vascular remodelling. Nat Commun 2014; 5: 3359.
29. Vacca P, Mingari MC, Moretta L. Natural killer cells in human pregnancy. J Reprod Immunol 2013; 97: 14-19.
30. Lash GE, Naruse K, Innes BA, Robson SC, Searle RF, Bulmer JN. Secretion of angiogenic growth factors by villous cytotrophoblast and extravillous trophoblast in early human pregnancy. Placenta 2010; 31: 545-548.
31. El Costa H, Casemayou A, Aguerre-Girr M, Rabot M, Berrebi A, Parant O et al. Critical and differential roles of NKp46-and NKp30-activating receptors expressed by uterine NK cells in early pregnancy. J Immunol 2008; 181: 3009-3017.
32. Madeja Z, Yadi H, Apps R, Boulenouar S, Roper SJ, Gardner L et al. Paternal MHC expression on mouse trophoblast affects uterine vascularization and fetal growth. Proc Natl Acad Sci USA 2011; 108: 4012-4017.
33. Xiong S, Sharkey AM, Kennedy PR, Gardner L, Farrell LE, Chazara O et al. Maternal uterine NK cell-activating receptor KIR2DS1 enhances placentation. J Clin Invest 2013; 123: 4264-4272.
34. Rajagopalan S, Long EO. A human histocompatibility leukocyte antigen (HLA)-G-specific receptor expressed on all natural killer cells. J Exp Med 1999; 189: 1093-1100.
35. Rajagopalan S, Long EO. KIR2DL4 (CD158d): an activation receptor for HLA-G. Front Immunol 2012; 3: 258.
36. Faure M, Long EO. KIR2DL4 (CD158d), an NK cell-activating receptor with inhibitory potential. J Immunol 2002; 168: 6208-6214.
37. Kikuchi-Maki A, Catina TL, Campbell KS. Cutting edge: KIR2DL4 transduces signals into human NK cells through association with the Fc receptor gamma protein. J Immunol 2005; 174: 3859-3863.
38. Rajagopalan S, Bryceson YT, Kuppusamy SP, Geraghty DE, van der Meer A, Joosten I et al. Activation of NK cells by an endocytosed receptor for soluble HLA-G. PLoS Biol 2006; 4: e9.
39. Park GM, Lee S, Park B, Kim E, Shin J, Cho K et al. Soluble HLA-G generated by proteolytic shedding inhibits NK-mediated cell lysis. Biochem Biophys Res Commun 2004; 313: 606-611.
40. Ponte M, Cantoni C, Biassoni R, Tradori-Cappai A, Bentivoglio G, Vitale C et al. Inhibitory receptors sensing HLA-G1 molecules in pregnancy: decidua-associated natural killer cells express LIR-1 and CD94/NKG2A and acquire p49, an HLA-G1-specific receptor. Proc Natl Acad Sci USA 1999; 96: 5674-5679.
41. Boyson JE, Erskine R, Whitman MC, Chiu M, Lau JM, Koopman LA et al. Disulfide bond-mediated dimerization of HLA-G on the cell surface. Proc Natl Acad Sci USA 2002; 99: 16180-16185.
42. Long EO, Rajagopalan S. HLA class I recognition by killer cell Ig-like receptors. Semin Immunol 2000; 12: 101-108.
43. Allan DS, Colonna M, Lanier LL, Churakova TD, Abrams JS, Ellis SA et al. Tetrameric complexes of human histocompatibility leukocyte antigen (HLA)-G bind to peripheral blood myelomonocytic cells. J Exp Med 1999; 189: 1149-1156.
44. Apps R, Gardner L, Sharkey AM, Holmes N, Moffett A. Ahomodimeric complex of HLA-G on normal trophoblast cells modulates antigen-presenting cells via LILRB1. Eur J Immunol 2007; 37: 1924-1937.
45. Clements CS, Kjer-Nielsen L, McCluskey J, Rossjohn J. Structural studies on HLA-G: implications for ligand and receptor binding. Hum Immunol 2007; 68: 220-226.
46. Kikuchi-Maki A, Yusa S, Catina TL, Campbell KS. KIR2DL4 is an IL-2-regulated NK cell receptor that exhibits limited expression in humans but triggers strong IFN-gamma production. J Immunol 2003; 171: 3415-3425.
47. Rajagopalan S. Endosomal signaling and a novel pathway defined by the natural killer receptor KIR2DL4 (CD158d). Traffic 2010; 11: 1381-1390.
48. Brusilovsky M, Cordoba M, Rosental B, Hershkovitz O, Andrake MD, Pecherskaya A et al. Genome-wide siRNA screen reveals a new cellular partner of NK cell receptor KIR2DL4: heparan sulfate directly modulates KIR2DL4-mediated responses. J Immunol 2013; 191: 5256-5267.
49. Rajagopalan S, Moyle MW, Joosten I, Long EO. DNA-PKcs controls an endosomal signaling pathway for a proinflammatory response by natural killer cells. Sci Signal 2010; 3: ra14.
50. Rajagopalan S, Lee EC, Duprie ML, Long EO. TNFR-associated factor 6 and TGF-beta-activated kinase 1 control signals for a senescence response by an endosomal NK cell receptor. J Immunol 2014; 192: 714-721.
51. Miah SM, Purdy AK, Rodin NB, MacFarlane AW 4th, Oshinsky J, Alvarez-Arias DA et al. Ubiquitylation of an internalized killer cell Ig-like receptor by Triad3A disrupts sustained NF-kappaB signaling. J Immunol 2011; 186: 2959-2969.
52. Scita G, Di Fiore PP. The endocytic matrix. Nature 2010; 463: 464-473.
53. Rajagopalan S, Long EO. Cellular senescence induced by CD158d reprograms natural killer cells to promote vascular remodeling. Proc Natl Acad Sci USA 2012; 109: 20596-20601.
54. Rodier F, Campisi J. Four faces of cellular senescence. J Cell Biol 2011; 192: 547-556.
55. Kuilman T, Peeper DS. Senescence-messaging secretome: SMS-ing cellular stress. Nat Rev Cancer 2009; 9: 81-94.
56. Coppe JP, Desprez PY, Krtolica A, Campisi J. The senescence-associated secretory phenotype: the dark side of tumor suppression. Annu Rev Pathol 2010; 5: 99-118.
57. Koopman LA, Kopcow HD, Rybalov B, MacFarlane AW 4th, Oshinsky J, Alvarez-Arias DA et al. Human decidual natural killer cells are a unique NK cell subset with immunomodulatory potential. J Exp Med 2003; 198: 1201-1212.
58. Rajagopalan S, Long EO. A positive role for senescence in reproduction? Aging (Albany NY) 2013; 5: 96-97.
59. Croy BA, Chen Z, Hofmann AP, Lord EM, Sedlacek AL, Gerber SA. Imaging of vascular development in early mouse decidua and its association with leukocytes and trophoblasts. Biol Reprod 2012; 87: 125.
60. Henson SM, Akbar AN. KLRG1-more than a marker for T cell senescence. Age (Dordr) 2009; 31: 285-291.
61. Chuprin A, Gal H, Biron-Shental T, Biran A, Amiel A, Rozenblatt S et al. Cell fusion induced by ERVWE1 or measles virus causes cellular senescence. Genes Dev 2013; 27: 2356-2366.
62. Goldman-Wohl D, Yagel S. United we stand not dividing: the syncytiotrophoblast and cell senescence. Placenta 2014; 35: 341-344.
63. Campisi J, d'Adda di Fagagna F. Cellular senescence: when bad things happen to good cells. Nat Rev Mol Cell Biol 2007; 8: 729-740.
64. Acosta JC, Banito A, Wuestefeld T, Georgilis A, Janich P, Morton JP et al. Acomplex secretory program orchestrated by the inflammasome controls paracrine senescence. Nat Cell Biol 2013; 15: 978-990.
65. Storer M, Mas A, Robert-Moreno A, Pecoraro M, Ortells MC, Di Giacomo V et al. Senescence is a developmental mechanism that contributes to embryonic growth and patterning. Cell 2013; 155: 1119-1130.
66. Munoz-Espin D, Canamero M, Maraver A, Gómez-López G, Contreras J, Murillo-Cuesta S et al. Programmed cell senescence during mammalian embryonic development. Cell 2013; 155: 1104-1118.
67. van Deursen JM. The role of senescent cells in ageing. Nature 2014; 509: 439-446.